Cite Filings / CRSP / 0001958244-25-001197
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
144

Sale of Securities

CRISPR Therapeutics AG · Filed 2025-02-18 · Acc 0001958244-25-001197

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2025-12-22 144 Sale of Securities
  • 2025-02-21 4 Chief Executive Officer sold 18,360 shares at $55.21 ($1,013,564)
  • 2025-02-19 4 Chief Operating Officer sold 333 shares at $52.80 ($17,582)
  • 2025-02-19 4 General Counsel and Secretary sold 11,542 shares at an average $53.67 ($619,492)
  • 2025-02-19 4 Chief Executive Officer sold 18,568 shares at an average $54.21 ($1,006,580)
  • 2025-02-18 144 Sale of Securities
  • 2024-11-12 144 Sale of Securities

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…